Related references
Note: Only part of the references are listed.On the limits of active module identification
Olga Lazareva et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Soluble Guanylate Cyclase Agonists Induce Bronchodilation in Human Small Airways
Cynthia J. Koziol-White et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
A New Pathway to Airway Relaxation: Targeting the Other Cyclase in Asthma
Maggie Lam et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
A Therapy for Most with Cystic Fibrosis
Christine E. Bear
CELL (2020)
Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine
Sara S. Bashraheel et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Toward a More Precise Future for Oncology
Yonina R. Murciano-Goroff et al.
CANCER CELL (2020)
Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1E17K-Mutant, ER-Positive Metastatic Breast Cancer
Lillian M. Smyth et al.
CLINICAL CANCER RESEARCH (2020)
Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease
Daniel P. Zimmer et al.
FRONTIERS IN PHARMACOLOGY (2020)
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2020)
Optical Mapping of cAMP Signaling at the Nanometer Scale
Andreas Bock et al.
CELL (2020)
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
Sepideh Sadegh et al.
NATURE COMMUNICATIONS (2020)
Nox1/4 inhibition exacerbates age dependent perivascular inflammation and fibrosis in a model of spontaneous hypertension
R. Nosalski et al.
PHARMACOLOGICAL RESEARCH (2020)
On the Clinical Pharmacology of Reactive Oxygen Species
Ana Casas et al.
PHARMACOLOGICAL REVIEWS (2020)
AKAP Signaling Islands: Venues for Precision Pharmacology
Mitchell H. Omar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype
Mahmoud H. Elbatreek et al.
PLOS BIOLOGY (2020)
Repository of proposed pathways and protein-protein interaction networks in age-related macular degeneration
Fran M. Pool et al.
NPJ AGING AND MECHANISMS OF DISEASE (2020)
New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology
Perrine Janiaud et al.
CANCER TREATMENT REVIEWS (2019)
Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke
Ana I. Casas et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
GUILDify v2.0: A Tool to Identify Molecular Networks Underlying Human Diseases, Their Comorbidities and Their Druggable Targets
Joaquim Aguirre-Plans et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
From single drug targets to synergistic network pharmacology in ischemic stroke
Ana I. Casas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Network-based prediction of drug combinations
Feixiong Cheng et al.
NATURE COMMUNICATIONS (2019)
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Jason K. Sicklick et al.
NATURE MEDICINE (2019)
Advances in gene therapy for cystic fibrosis lung disease
Ziying Yan et al.
HUMAN MOLECULAR GENETICS (2019)
Assessment of network module identification across complex diseases
Sarvenaz Choobdar et al.
NATURE METHODS (2019)
Elexacaftor/Ivacaftor/Tezacaftor: First Approval
Sheridan M. Hoy
DRUGS (2019)
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration
Andrew P. Voigt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
IID 2018 update: context-specific physical protein-protein interactions in human, model organisms and domesticated species
Max Kotlyar et al.
NUCLEIC ACIDS RESEARCH (2019)
Single-nuclei RNA-seq on human retinal tissue provides improved transcriptome profiling
Qingnan Liang et al.
NATURE COMMUNICATIONS (2019)
L-Citrulline increases nitric oxide and improves control in obese asthmatics
Fernando Holguin et al.
JCI INSIGHT (2019)
WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research
Denise N. Slenter et al.
NUCLEIC ACIDS RESEARCH (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
HER kinase inhibition in patients with HER2-and HER3-mutant cancers
David M. Hyman et al.
NATURE (2018)
Statistical and Machine Learning Approaches to Predict Gene Regulatory Networks From Transcriptome Datasets
Keiichi Mochida et al.
FRONTIERS IN PLANT SCIENCE (2018)
Proximal Pathway Enrichment Analysis for Targeting Comorbid Diseases via Network Endopharmacology
Joaquim Aguirre-Plans et al.
PHARMACEUTICALS (2018)
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs
Hiroshi Maeda et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection
Friederike Langhauser et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2018)
NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage
Ana I. Casas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects
Matthieu Chartier et al.
BMC PHARMACOLOGY & TOXICOLOGY (2017)
Simple and complex retinal dystrophies are associated with profoundly different disease networks
Christina Kiel et al.
SCIENTIFIC REPORTS (2017)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Adam C. Palmer et al.
CELL (2017)
Critical Review of Umbrella, Basket, and Platform Designs for Oncology Clinical Trials
Richard Simon
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease
Stephen P. Gray et al.
DIABETOLOGIA (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
On the performance of de novo pathway enrichment
Richa Batra et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2017)
Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling
Stephen P. Gray et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Clinical Relevance of Cyclic GMP Modulators: A Translational Success Story of Network Pharmacology
J. M. Oettrich et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
NOS knockout or inhibition but not disrupting PSD-95-NOS interaction protect against ischemic brain damage
Christoph Kleinschnitz et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment
Keith T. Schmidt et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Universal resilience patterns in complex networks (vol 530, pg 307, 2016)
Jianxi Gao et al.
NATURE (2016)
Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci
David Ellinghaus et al.
NATURE GENETICS (2016)
Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature
Paramasivan Poornima et al.
PHARMACOLOGICAL RESEARCH (2016)
Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets
Arunachalam Vinayagam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Systems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General Case
Farshid S. Garmaroudi et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Pharmacology and Clinical Drug Candidates in Redox Medicine
V. Thao-Vi Dao et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Clinical Relevance of Biomarkers of Oxidative Stress
Jeroen Frijhoff et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Time for one-person trials
Nicholas J. Schork
NATURE (2015)
Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies
Judy H. Cho et al.
NATURE MEDICINE (2015)
Uncovering disease-disease relationships through the incomplete interactome
Joerg Menche et al.
SCIENCE (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation
Pamela W. M. Kleikers et al.
SCIENTIFIC REPORTS (2015)
NADPH Oxidase, NOX1, Mediates Vascular Injury in Ischemic Retinopathy
Jennifer L. Wilkinson-Berka et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
Pawel Buczkowicz et al.
NATURE GENETICS (2014)
Early Diagnosis of Complex Diseases by Molecular Biomarkers, Network Biomarkers, and Dynamical Network Biomarkers
Rui Liu et al.
MEDICINAL RESEARCH REVIEWS (2014)
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
Deborah M. Cholon et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
CUSP9*treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
Richard E. Kast et al.
ONCOTARGET (2014)
NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus-Accelerated Atherosclerosis
Stephen P. Gray et al.
CIRCULATION (2013)
Animal Models in Obesity and Hypertension
Gabriella Segal-Lieberman et al.
CURRENT HYPERTENSION REPORTS (2013)
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer
Jordan M. Winter et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Dysfunctional nitric oxide signalling increases risk of myocardial infarction
Jeanette Erdmann et al.
NATURE (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Exploring the human diseasome: the human disease network
Kwang-Il Goh et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2012)
Personalized Cardiovascular Medicine and Drug Development Time for a New Paradigm
Joseph Loscalzo
CIRCULATION (2012)
NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury
Pamela W. M. Kleikers et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Ivacaftor
Pamela B. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Diagnosing the decline in pharmaceutical R&D efficiency
Jack W. Scannell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Animal models for the study of arterial hypertension
Waleska C. Dornas et al.
JOURNAL OF BIOSCIENCES (2011)
Believe it or not: how much can we rely on published data on potential drug targets?
Florian Prinz et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
Alexa B. Turke et al.
CANCER CELL (2010)
Rationalizing the chemical space of protein-protein interaction inhibitors
Olivier Sperandio et al.
DRUG DISCOVERY TODAY (2010)
Patrick Vallance
Patrick Vallance
NATURE REVIEWS DRUG DISCOVERY (2010)
Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration
Christoph Kleinschnitz et al.
PLOS BIOLOGY (2010)
Are animal models predictive for humans?
Niall Shanks et al.
Philosophy Ethics and Humanities in Medicine (2009)
Prognostic versus predictive value of biomarkers in oncology
C. N. A. M. Oldenhuis et al.
EUROPEAN JOURNAL OF CANCER (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
The human disease network
Kwang-Il Goh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
1,026 experimental treatments in acute stroke
VE O'Collins et al.
ANNALS OF NEUROLOGY (2006)
sc-PDB: an annotated database of druggable binding sites from the protein data bank
E Kellenberger et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
DrugBank: a comprehensive resource for in silico drug discovery and exploration
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2006)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
E Takimoto et al.
NATURE MEDICINE (2005)
PISCES: a protein sequence culling server
GL Wang et al.
BIOINFORMATICS (2003)
Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification
LG Ogden et al.
HYPERTENSION (2000)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
